These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8529445

  • 21. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 22. Results of an aggressive approach to resection of locally recurrent rectal cancer.
    Wells BJ, Stotland P, Ko MA, Al-Sukhni W, Wunder J, Ferguson P, Lipa J, Last L, Smith AJ, Swallow CJ.
    Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
    [Abstract] [Full Text] [Related]

  • 23. [Extended resection of locally advanced primary and recurrent rectal carcinomas by interdisciplinary cooperation of various surgical specialties].
    Jürgens C, Peitgen K, Walz MK, Krege S, Eigler FW.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Feb; 115():338-41. PubMed ID: 9931636
    [Abstract] [Full Text] [Related]

  • 24. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.
    Schiller DE, Cummings BJ, Rai S, Le LW, Last L, Davey P, Easson A, Smith AJ, Swallow CJ.
    Ann Surg Oncol; 2007 Oct; 14(10):2780-9. PubMed ID: 17638059
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780
    [Abstract] [Full Text] [Related]

  • 28. Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer.
    Kanemitsu Y, Hirai T, Komori K, Kato T.
    Dis Colon Rectum; 2010 May 15; 53(5):779-89. PubMed ID: 20389212
    [Abstract] [Full Text] [Related]

  • 29. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S.
    Hepatogastroenterology; 2003 May 15; 50(51):700-3. PubMed ID: 12828064
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Local recurrence after mesorectal excision for rectal cancer.
    Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC.
    Eur J Surg Oncol; 2002 Mar 15; 28(2):126-34. PubMed ID: 11884047
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Results of surgical treatment of residual and recurrent anal tumors].
    Vorob'ev GI, Shelygin IuA, Nechushkin MI, Rybakov EG.
    Khirurgiia (Mosk); 2008 Mar 15; (8):4-9. PubMed ID: 18833142
    [Abstract] [Full Text] [Related]

  • 35. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A.
    Gynecol Oncol; 2006 Dec 15; 103(3):1023-30. PubMed ID: 16890276
    [Abstract] [Full Text] [Related]

  • 36. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):745-52. PubMed ID: 16199310
    [Abstract] [Full Text] [Related]

  • 37. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, Rodriguez-Bigas MA.
    Ann Surg Oncol; 2007 Jun 01; 14(6):1870-7. PubMed ID: 17406945
    [Abstract] [Full Text] [Related]

  • 38. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
    Zhuo HQ, Zhou YB, Lü L, Zhou J, Yang WY, Li YJ.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):820-2. PubMed ID: 19595121
    [Abstract] [Full Text] [Related]

  • 39. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D, Kyau-Ummen B, Halbfass HJ.
    Chirurg; 2002 Mar 31; 73(3):245-54. PubMed ID: 11963499
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.